PLEDPHARMA AB (PUBL) |
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/06 | Transcript : Egetis Therapeutics AB - Special Call | |
| 19/06 | Egetis Therapeutics AB Announces Topline Results of the Phase 2 Triac Trial II with Emcitate for MCT8 Deficiency | CI |
Chart calendar PledPharma AB (publ)
926050d7a51f70743023b1ecbb566.HLTna--v2md7OSXjrY4pMx1nY6t57j3A0MCUxXGK8vg.TIe_Ko2euxUSWke69Lx9XUU-JshApnmh5fHd9x7Sw6dRxoUNou2pFjxQTg~a84f257a3b1256929e1bab36b0d65160
Upcoming events on PledPharma AB (publ)
Past events on PledPharma AB (publ)
| 20/06/2024 11:30 am | Emcitate® (tiratricol) Phase 2 Triac Trial II Results Call |
| 06/05/2024 | Annual General Meeting |
| 03/05/2024 | Q1 2024 Earnings Release |
| 18/04/2024 09:20 pm | Redeye Investor Forum |
| 05/03/2024 | Carnegie Healthcare Conference |
| 22/02/2024 | Q4 2023 Earnings Release |
| 19/12/2023 | Investor Day |
| 08/11/2023 | Q3 2023 Earnings Release |
| 22/08/2023 | Q2 2023 Earnings Release |
| 30/05/2023 09:30 am | ABGSC Life Science Summit |
| 27/04/2023 | Annual General Meeting |
| 26/04/2023 | Q1 2023 Earnings Release |
| 22/02/2023 | FY 2022 Earnings Release |
| 08/11/2022 | Q3 2022 Earnings Release |
| 19/10/2022 | American Thyroid Association Meeting |
| 13/10/2022 04:30 pm | Capital Markets Day |
| 03/10/2022 | International Child Neurology Congress |
| 15/09/2022 | European Society of Paediatric Endocrinology Meeting |
| 10/09/2022 | European Thyroid Association Meeting |
| 07/09/2022 | Pareto Securities Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 82,6 73,0 13.07% | 40,7 39,8 2.28% | 38,5 49,1 -21.56% | 22,6 29,2 -22.63% | 57,6 35,4 62.54% | 61,0 |
|
EBITDA Million SEK | Released Forecast Spread | -66,5 -89,2 25.49% | -178 -133 -33.78% | -103 -127 19.03% | -195 -163 -19.8% | -321 -286 -12.41% | -278 |
|
EBIT Million SEK | Released Forecast Spread | -66,7 -89,4 25.43% | -178 -133 -34.01% | -106 -128 17.18% | -198 -165 -19.71% | -325 -288 -12.92% | -279 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.05% | -293 |
|
Net income Million SEK | Released Forecast Spread | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.08% | -293 |
|
EPS SEK | Released Forecast Spread | -1,20 -1,49 19.24% | -2,70 -1,35 -100.44% | -0,60 -0,78 23.04% | -1,00 -0,85 -17.19% | -1,30 -1,22 -6.57% | -1,02 |
| Announcement Date | 18/02/20 | 17/02/21 | 17/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 5,02 10,4 -51.61% | 5,10 10,4 -50.87% | 5,70 10,4 -45.09% | 6,80 5,62 20.98% | 5,90 5,25 12.3% | 12,2 5,25 132.2% | 32,6 8,30 292.77% | 12,1 10,0 21% | 11,7 | 13,6 | 14,1 | 21,0 | 35,0 | |
|
EBITDA Million SEK | Released Forecast Spread | -34,3 -45,4 24.38% | -54,7 -45,4 -20.57% | -77,5 -45,4 -70.83% | -74,0 -82,0 9.76% | -79,4 -71,7 -10.79% | -85,6 -73,1 -17.17% | -82,2 -83,9 2.01% | -86,0 | -85,5 | -89,3 | -94,3 | -77,0 | -64,0 | |
|
EBIT Million SEK | Released Forecast Spread | -35,0 -45,4 22.89% | -55,4 -45,4 -22.11% | -78,2 -45,4 -72.37% | -74,9 -82,0 8.66% | -80,3 -71,7 -12.05% | -86,5 -73,1 -18.4% | -83,1 -83,9 0.93% | -68,6 -86,0 20.23% | -85,5 | -89,3 | -94,3 | |||
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -33,2 -48,0 30.77% | -53,9 -48,0 -12.24% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,1 -87,3 1.34% | -75,0 -89,4 16.06% | -86,3 | -92,9 | -98,1 | -77,0 | -64,0 | |
|
Net income Million SEK | Released Forecast Spread | -28,8 | -33,2 -48,0 30.77% | -53,1 -48,0 -10.56% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,3 -87,3 1.11% | -75,0 -89,4 16.06% | -86,3 | -92,9 | -98,1 | ||
|
EPS SEK | Released Forecast Spread | -0,20 | -0,20 -0,22 10.63% | -0,30 -0,22 -34.06% | -0,40 -0,22 -78.75% | -0,30 -0,35 13.79% | -0,30 -0,28 -5.46% | -0,30 -0,26 -14.6% | -0,30 -0,32 6.81% | -0,30 -0,31 1.77% | -0,30 | -0,32 | -0,29 | -0,20 | -0,16 |
| Announcement Date | 26/04/22 | 19/08/22 | 08/11/22 | 22/02/23 | 26/04/23 | 22/08/23 | 08/11/23 | 22/02/24 | 03/05/24 | - | - | - | - | - |
More events
Past sector events for PledPharma AB (publ)
| 12/07/2024 01:30 am | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 09/07/2024 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 08/07/2024 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 05/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 07/06/2024 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
- Stock Market
- Equities
- EGTX Stock
- Stock
- Calendar PledPharma AB (publ)
